Literature DB >> 8775741

Progress in adult acute lymphoblastic leukemia.

F R Appelbaum.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8775741      PMCID： PMC1303400     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  11 in total

Review 1.  Biology and treatment of adult acute lymphoblastic leukemia.

Authors:  L Levitt; R Lin
Journal:  West J Med       Date:  1996-02

2.  Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults.

Authors:  D Hoelzer; E Thiel; H Löffler; T Büchner; A Ganser; G Heil; P Koch; M Freund; H Diedrich; H Rühl
Journal:  Blood       Date:  1988-01       Impact factor: 22.113

3.  Presence of clonal chromosome abnormalities in virtually all cases of acute lymphoblastic leukemia.

Authors:  D L Williams; S Raimondi; G Rivera; S George; C W Berard; S B Murphy
Journal:  N Engl J Med       Date:  1985-09-05       Impact factor: 91.245

4.  Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay.

Authors:  S N Powell; J S DeFrank; P Connell; M Eogan; F Preffer; D Dombkowski; W Tang; S Friend
Journal:  Cancer Res       Date:  1995-04-15       Impact factor: 12.701

5.  Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells.

Authors:  K J Russell; L W Wiens; G W Demers; D A Galloway; S E Plon; M Groudine
Journal:  Cancer Res       Date:  1995-04-15       Impact factor: 12.701

6.  Detection of BCR-ABL fusion genes in adult acute lymphoblastic leukemia by the polymerase chain reaction.

Authors:  J P Radich; K J Kopecky; D H Boldt; D Head; M L Slovak; R Babu; J Kirk; A Lee; P Kessler; F Appelbaum
Journal:  Leukemia       Date:  1994-10       Impact factor: 11.528

7.  Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides.

Authors:  C Szczylik; T Skorski; N C Nicolaides; L Manzella; L Malaguarnera; D Venturelli; A M Gewirtz; B Calabretta
Journal:  Science       Date:  1991-08-02       Impact factor: 47.728

8.  Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation.

Authors:  D C Matthews; F R Appelbaum; J F Eary; D R Fisher; L D Durack; S A Bush; T E Hui; P J Martin; D Mitchell; O W Press
Journal:  Blood       Date:  1995-02-15       Impact factor: 22.113

9.  Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases.

Authors:  F M Uckun; W E Evans; C J Forsyth; K G Waddick; L T Ahlgren; L M Chelstrom; A Burkhardt; J Bolen; D E Myers
Journal:  Science       Date:  1995-02-10       Impact factor: 47.728

10.  Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia.

Authors:  K M Sullivan; P L Weiden; R Storb; R P Witherspoon; A Fefer; L Fisher; C D Buckner; C Anasetti; F R Appelbaum; C Badger
Journal:  Blood       Date:  1989-05-01       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.